September 21, 2017 2:31 AM ET


Company Overview of U3 Pharma GmbH

Company Overview

U3 Pharma GmbH, a clinical-stage biopharmaceutical company, develops protein therapeutics for the treatment of cancer. The company’s drug development pipeline comprises antibodies and antibody-drug-conjugates. Its medicines are directed against cancer but selected drugs also have potential for treating cardiovascular or metabolic diseases. The company was founded in 2001 and is based in Planegg, Germany. As of June 19, 2008, U3 Pharma GmbH operates as a subsidiary of Daiichi Sankyo Company, Limited.

Fraunhoferstr. 22

Planegg,  82152


Founded in 2001


49 89 8103 9100


49 89 8103 9199

Key Executives for U3 Pharma GmbH

Co-Founder, Chief Executive Officer and Member of Board of Management
Scientific Founder and Director
Age: 73
Co-Founder and Director of R&D
Co-Founder and Director of R&D
Co-Founder and Director of R&D
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
3B Pharmaceuticals GmbH Europe
Accelsiors Group International Europe
Aenova Group GmbH Europe
Aenova Holding GmbH Europe
AiCuris GmbH & Co. KG Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact U3 Pharma GmbH, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at